These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 33955524)
1. [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer. Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955524 [TBL] [Abstract][Full Text] [Related]
2. [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer. Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34878151 [TBL] [Abstract][Full Text] [Related]
3. [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway. Jin F; Wang H; Li D; Fang C; Li W; Shi Q; Diao Y; Ding Z; Dai X; Tao L; Sunagawa M; Wu F; Qian Y; Liu Y Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35147201 [TBL] [Abstract][Full Text] [Related]
4. [Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells. Chen YH; Zhou BY; Wu XJ; Xu JF; Zhang JA; Chen YH; Liang SS Oncol Rep; 2021 Feb; 45(2):786. PubMed ID: 33416180 [TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] Cripto‑1 promotes epithelial‑mesenchymal transition in prostate cancer via Wnt/β‑catenin signaling. Liu Y; Qin Z; Yang K; Liu R; Xu Y Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38639182 [TBL] [Abstract][Full Text] [Related]
6. [Corrigendum] Repression of Smad4 by miR‑205 moderates TGF‑β-induced epithelial‑mesenchymal transition in A549 cell lines. Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z Int J Oncol; 2021 Feb; 58(2):276-277. PubMed ID: 33491753 [TBL] [Abstract][Full Text] [Related]
7. [Corrigendum] Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma. Yi Z; Pu Y; Gou R; Chen Y; Ren X; Liu W; Dong P Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34981824 [TBL] [Abstract][Full Text] [Related]
8. [Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway. Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866758 [TBL] [Abstract][Full Text] [Related]
9. [Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway. Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 34981815 [TBL] [Abstract][Full Text] [Related]
10. [Corrigendum] ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation. Feng J; Xiao T; Lu SS; Hung XP; Yi H; He QY; Huang W; Tang YY; Xiao ZQ Int J Oncol; 2019 Nov; 58(1):133-134. PubMed ID: 33899924 [TBL] [Abstract][Full Text] [Related]
11. [Corrigendum] Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPARγ pathway. Song M; Tian X; Lu M; Zhang X; Ma K; Lv Z; Wang Z; Hu Y; Xun C; Zhang Z; Wang S Int J Oncol; 2024 May; 64(5):. PubMed ID: 38488025 [TBL] [Abstract][Full Text] [Related]
12. [Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35014687 [TBL] [Abstract][Full Text] [Related]
13. [Corrigendum] The novel anti‑neuroblastoma agent PF403, inhibits proliferation and invasion Li C; Li Y; Lv H; Li S; Tang K; Zhou W; Yu S; Chen X Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069224 [TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] SB‑T‑121205, a next‑generation taxane, enhances apoptosis and inhibits migration/invasion in MCF‑7/PTX cells. Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484397 [TBL] [Abstract][Full Text] [Related]
15. [Corrigendum] lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway. Wang H; Zhang P Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35119080 [TBL] [Abstract][Full Text] [Related]
16. [Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma. Li L; Yu J; Duan Z; Dang HX Int J Oncol; 2020 Dec; 57(6):1381. PubMed ID: 33173961 [TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma. Li L; Yu J; Duan Z; Dang HX Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35119078 [TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance. Zhu X; Liu J; Xu X; Zhang C; Dai D Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35088881 [TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Ji J; Shen I; Li Y; Liu Y; Shang Z; Niu Y Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477123 [TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer. Iida K; Zheng R; Shen R; Nanus DM Int J Oncol; 2024 Nov; 65(5):. PubMed ID: 39301647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]